FGF21 Agonists: An Emerging Therapeutic for Metabolic Dysfunction-Associated Steatohepatitis and Beyond
Article in Journal of Hepatology (May 2024)
The most recent citing publications are shown below. View all 278 publications that cite this research output on Dimensions.
Article in Journal of Hepatology (May 2024)
Article in Journal of Experimental Medicine (May 2024)
Article in Metabolism (April 2024)